Benzylpiperazine (BZP): The Expert Advisory Committee on Drugs (EACD) Advice to the Minister

ndp Web Page
Printed 09/10/2010 01:25:10 PM Back Print

Publications

Benzylpiperazine (BZP): The Expert Advisory Committee on Drugs (EACD) Advice to the Minister

Date of publication: Apr 2004

The Expert Advisory Committee on Drugs (EACD) considered benzylpiperazine (BZP) and related substances at its meeting of 19 March 2004.

The EACD considered evidence provided by the Ministry of Health.s secretariat, the New Zealand drug enforcement agencies and others. The EACD considered the information before it in the terms of the criteria the EACD must apply before making a recommendation to the Minister.

It concluded that there was insufficient information available on which to base a recommendation to classify these substances in the schedules of the Misuse of Drugs Act.1975. However, the EACD brings to your attention some matters the committee members considered important and which, if acted on, may form the basis for reconsideration by the EACD.

Document availability

This publication is available in PDF format.

EACD advice on Benzylpiperazine (PDF, 132 KB)